Topical BHRT Creams
Overview
Topical creams are among the most commonly prescribed BHRT delivery methods. They are applied directly to the skin, where hormones are absorbed through the dermal layers into systemic circulation.
Clinical Considerations
Creams are often used for estrogen, progesterone, testosterone, and DHEA therapy. They allow for flexible dosing and may reduce gastrointestinal involvement since they bypass oral ingestion. Providers can adjust concentrations precisely, making creams suitable for patients who require gradual dose titration.
Advantages
Topical creams offer ease of use, non-invasive administration, and customizable dosing. They may be well tolerated by patients who prefer to avoid injections or oral medications. For many patients, creams provide steady symptom relief when applied consistently and correctly.
Limitations
Absorption may vary depending on skin integrity, application site, and patient adherence. Improper application or inconsistent use can lead to fluctuating hormone levels. There is also a risk of unintended hormone transfer through skin-to-skin contact if proper precautions are not followed.
BHRT Troches (Sublingual or Buccal)
Troches are small, dissolvable lozenges designed to be placed under the tongue (sublingual) or between the cheek and gum (buccal). Hormones are absorbed through the oral mucosa directly into the bloodstream.
Clinical Considerations
Troches are commonly prescribed for estrogen, progesterone, and testosterone. By bypassing first-pass liver metabolism, troches may result in faster absorption compared to oral capsules. They are often used when precise systemic delivery is desired without injections.
Advantages
Troches allow for relatively rapid absorption and consistent dosing when used properly. They can be flavored to improve patient compliance and are useful for patients who cannot tolerate topical preparations or injections.
Limitations
Troches require patient cooperation and correct administration technique. Eating, drinking, or speaking too soon after placement may reduce absorption. Some patients experience oral irritation or dislike the taste or texture, which can affect adherence.
Injectable BHRT
Injectable BHRT delivers hormones directly into muscle or subcutaneous tissue, allowing for controlled systemic absorption over time. This method is commonly used for testosterone and, in some cases, estrogen therapy.
Clinical Considerations
Injectables are often selected for patients requiring higher doses, more stable blood levels, or who have not achieved adequate symptom control with topical or sublingual methods. Dosing schedules are determined by the provider and may range from weekly to bi-weekly or longer intervals.
Advantages
Injectable BHRT offers predictable absorption, consistent serum hormone levels, and reduced variability compared to topical methods. It eliminates concerns related to skin absorption or oral compliance and is often preferred in clinical settings for certain patient populations.
Limitations
Injections are invasive and may be associated with discomfort, injection-site reactions, or anxiety for some patients. They require proper administration technique and, in some cases, in-office visits or patient training for self-administration.
Comparing BHRT Delivery Methods
No single delivery method is universally superior. The choice depends on multiple individualized factors, including:
-
Hormone type and dose required
-
Patient symptoms and severity
-
Absorption variability
-
Medical history and risk profile
-
Lifestyle, preferences, and adherence considerations
-
Provider experience and clinical judgment
Providers may also change delivery methods over time based on patient response, lab results, or evolving clinical needs.
Safety, Monitoring, and Compliance
All BHRT delivery methods require ongoing medical supervision. Compounded BHRT medications are not FDA-approved and may carry variability in potency and absorption. Regular laboratory testing, symptom review, and dose adjustments are essential to minimize risks and optimize outcomes.
Patients should never alter their delivery method, dose, or frequency without consulting their healthcare provider.
The Role of Compounding Pharmacies
Specialized compounding pharmacies work closely with providers to prepare BHRT formulations in creams, troches, or injectables according to prescription specifications. This collaboration supports individualized care, flexible dosing options, and consistent quality control under sterile and non-sterile compounding standards.
Making an Informed Decision
Choosing the most appropriate BHRT delivery method is a clinical decision that should be made collaboratively between patient and provider. Understanding the benefits and limitations of creams, troches, and injections allows for realistic expectations, improved adherence, and safer hormone therapy management.
With proper evaluation, personalized formulation, and ongoing monitoring, BHRT delivery methods can be effectively aligned with patient needs and therapeutic goals—supporting balanced hormone health and improved quality of life.